Potential utility of early metabolic response by 18F-2-fluoro-2- deoxy-d-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy

G. Zucchini, S. Quercia, C. Zamagni, D. Santini, M. Taffurelli, S. Fanti, A. A. Martoni

Research output: Contribution to journalArticle

Abstract

Introduction: To assess 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography's (18F-FDG-PET/CT) potential clinical utility to allow early treatment changes during preoperative chemotherapy (PCT) in patients with early/locally advanced breast cancer (BC). Patients and methods: Sixty newly diagnosed early/locally advanced BC patients received 6-8 cycles of PCT. Optimal pathologic response (pR) was the absence of cancer cells in breast and axillary lymph nodes. All other conditions were defined as pathologic non-response (pNR). 18F-FDG-PET/CT maximum standardised uptake value (SUVmax) was measured at baseline and after 2 cycles of PCT. Metabolic response was defined as SUVmax percentage changes (Δ-SUV) >50% and was compared with pR rates. Results: Thirteen (22%) patients achieved pR; according to immunohistochemistry, 16% of ER-positive/HER2-negative patients, 29% and 27% of HER2-positive and triple negative patients respectively achieved pR. 18F-FDG-PET/CT showed the highest specificity (38%) and negative predictive value (100%) in ER-positive/HER2-negative patients. In this subgroup, at a median follow-up of 36.6 months, median disease-free survival was still not reached in metabolic responders while it was 37 months in metabolic non-responders (p = 0.049). Discussion: Early metabolic non-response was always associated to pNR and poor prognosis in ER-positive/HER2-negative patients. In this subgroup, 18F-FDG-PET/CT might be useful to select patients who will probably benefit from early therapeutic strategy modifications.

Original languageEnglish
Pages (from-to)1539-1545
Number of pages7
JournalEuropean Journal of Cancer
Volume49
Issue number7
DOIs
Publication statusPublished - May 2013

Keywords

  • F-2-fluoro-2-deoxy-d- glucose positron emission tomography/computed tomography
  • Breast cancer
  • Early response evaluation
  • Optimal pathologic response
  • Preoperative chemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Potential utility of early metabolic response by 18F-2-fluoro-2- deoxy-d-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy'. Together they form a unique fingerprint.

  • Cite this